HUMDF (Hua Medicine) Other Current Receivables : $0.63 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Hua Medicine Other Current Receivables?

Hua Medicine's Other Current Receivables for the quarter that ended in Dec. 2024 was $0.63 Mil.

Hua Medicine's quarterly Other Current Receivables declined from Dec. 2023 ($0.93 Mil) to Jun. 2024 ($0.61 Mil) but then increased from Jun. 2024 ($0.61 Mil) to Dec. 2024 ($0.63 Mil).

Hua Medicine's annual Other Current Receivables declined from Dec. 2022 ($58.85 Mil) to Dec. 2023 ($0.93 Mil) and declined from Dec. 2023 ($0.93 Mil) to Dec. 2024 ($0.63 Mil).

Hua Medicine Other Current Receivables Historical Data

The historical data trend for Hua Medicine's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hua Medicine Other Current Receivables Chart

Hua Medicine Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Current Receivables

Get a 7-Day Free Trial

1.41

1.52

58.85

0.93

0.63

Hua Medicine Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Current Receivables	Get a 7-Day Free Trial												58.85	1.10	0.93	0.61	0.63

Hua Medicine Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Hua Medicine Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Hua Medicine's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Hua Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hua Medicine (OTCPK:HUMDF) » Definitions » Other Current Receivables

Traded in Other Exchanges

02552:Hong Kong

Address

Lane 36, Xuelin Road, Hua Medicine, Building 2, Pudong New Area, Shanghai, CHN, 201203

Website

https://www.huamedicine.com

Hua Medicine is an investment holding company. It is engaged in the development and commercialization of a first-in-class oral drug, Dorzagliatin or HMS5552, for the treatment of Type 2 diabetes. The group majorly operates in the PRC.